CBP why is the price of this stock so undervalued now. They have huge assets increased now and liabilities are 1/10th there assets. Seems to me they are way down in price for sure. grew assets by 46 million over the year Total assets $ 109,896,164 $ 73,145,079
the float has not changed as well in a year.
Common stock ($0.001 par value, 100,000,000 shares, authorized; 37,239,536 issued and outstanding as of October 31,2011 and October 31, 2010, respectively)
shareholders equity grew by 30 million or almost fifty percent to almost 3.00 a share at .71 sale price
they did have a huge increase in both revenues and gross profit this year as well
Sales, net $ 72,713,748 $ 55,183,941
Cost of goods sold 29,531,087 25,765,835
Gross profit 43,182,661 29,418,106
The most important part is there share price is the same as there earnings per share and this is a Pharmaceutical company and to me at .70 EPS should be well above 7.00 a share now. I will have to do more research here now into the next 10q this next month
News 
Market Data 
Discover 
